Variable CD52 expression in mature T cell and NK cell malignancies: Implications for alemtuzumab therapy

Liuyan Jiang, Constance M. Yuan, Julia Hubacheck, John Edward Janik, Wyndham Wilson, John C. Morris, Gregory A. Jasper, Maryalice Stetler-Stevenson

Research output: Contribution to journalArticlepeer-review

89 Scopus citations

Fingerprint

Dive into the research topics of 'Variable CD52 expression in mature T cell and NK cell malignancies: Implications for alemtuzumab therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences